Androgen-independent growth of tumor cells can be mediated by the hormone RLN2, which can activate the AR signaling pathway by inducing the formation of the β-catenin–AR complex and its translocation to the nucleus [27,55]. The gene discussed is AR; the disease is neoplasm.